PRL
- UID
- IMP/IVD/2022/000198_9af47ee0c5f4d523156cb00c9b724b22_f98c6438fe1069725807673bbfd0cb6d
- Device class
- Class B
- Brand name
- ichroma™ Myoglobin neo
- License holder
- CPC DIAGNOSTICS PVT.LTD
- Approving authority
- CDSCO
- Product information
- ichromaTM PRL is a fluorescence immunoassay (ichroma™ Myoglobin neo) for the quantitative determination of Prolactin (ichroma™ Myoglobin neo) in human serum/plasma. It is useful as an aid in management and monitoring of hypothalamic-pituitary disorders
PRL is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000198_9af47ee0c5f4d523156cb00c9b724b22_f98c6438fe1069725807673bbfd0cb6d. This device is marketed under the brand name ichroma™ Myoglobin neo. The license holder is CPC DIAGNOSTICS PVT.LTD, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.